2013•European Society of RadiologyOpen access

Are fiducial markers still the gold standard for prostate image guided radiation therapy (IGRT)?

Thomas Eade

Open full text 0 citations

Abstract

Poster: RANZCR ASM 2013 / R-0136 / Are fiducial markers still the gold standard for prostate image guided radiation therapy (IGRT)? by: T. Eade, A. Kneebone, L. Guo; St Leonards/AU

About this research paper

What this paper is about

Poster: RANZCR ASM 2013 / R-0136 / Are fiducial markers still the gold standard for prostate image guided radiation therapy (IGRT)? by: T. Eade, A. Kneebone, L. Guo; St Leonards/AU

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Poster: RANZCR ASM 2013 / R-0136 / Are fiducial markers still the gold standard for prostate image guided radiation therapy (IGRT)? by: T. Eade, A. Kneebone, L. Guo; St Leonards/AU

Key concepts: Image-guided radiation therapy, Fiducial marker, Gold standard (test), Prostate cancer, Medicine, Radiation therapy, Prostate, Nuclear medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Are fiducial markers still the gold standard for prostate image guided radiation therapy (IGRT)? — Research Paper | ScholarLens